GC Biopharma USA, Inc., a leader in plasma-derived products, announced today that it will host a sponsored symposium and present two scientific posters at the 2025 Immunoglobulin National Society ...
This Poster will be available on the Company’s website on the “Publications: Posters & Presentations” page under the “Our Science” tab. ORLYNVAH™ is a novel oral penem antibiotic for the treatment of ...
"At Catalyst, everything begins with patients. Our presence at these scientific meetings reflects our ongoing commitment to advancing differentiated therapies that can meaningfully impact the lives of ...
Detailed price information for Livanova Plc OR Sh (LIVN-Q) from The Globe and Mail including charting and trades.
TORONTO--(BUSINESS WIRE)--Vasomune Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development of AV-001 for the treatment of diseases associated with vascular dysfunction ...
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device ...
Bright Minds Biosciences will present scientific posters about various programs in development, including BMB-101, BMB-201 and BMB-202 Bright Minds Biosciences will participate in BIO Europe ...
Lorem, a nonprofit foundation, announced today that it will hold its third annual Nano-rare Patient Colloquium in Cambridge, Mass., where n-Lorem leaders and experts in the field will share updates on ...
BOULDER, Colo.--(BUSINESS WIRE)--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that the company will present data on sevasemten, an ...
Presenting your poster at a Labroots Virtual Event can provide valuable research insights and feedback from peers in the comfort of your home or office. Every Labroots virtual event features a virtual ...
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)-- Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results